Status:
COMPLETED
Characterization of Head and Neck Malignant Tumors Using an Electronic Nose
Lead Sponsor:
Carmel Medical Center
Collaborating Sponsors:
Technion, Israel Institute of Technology
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Head and neck tumors are common in the general population especially in high risk groups of smokers and alcohol abusers, as well as after exposure to various environmental factors. Diagnosis is based ...
Detailed Description
Approximately 60,000 new cases of head and neck cancer are diagnosed in the U.S. each year, accounting for about 5% of cancer cases diagnosed in North America and approximately 1-2% of cancer deaths. ...
Eligibility Criteria
Inclusion
- Patients with head and neck tumors
- A patient can understand, read and sign the informed consent form, signing a consent form
- Age over 18
Exclusion
- Known or second primary head and neck cancer
- Surgery to head and neck index tumor except for tumor biopsy
- Unsteady comorbidity
- Pregnancy
- breastfeeding
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01816919
Start Date
November 1 2010
End Date
September 1 2013
Last Update
July 31 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.